Medical/Pharmaceuticals

2026 International Day of Older Persons: Dimora Medical Supports Dignified Longevity with Advanced Home Wound Care

NEW YORK, Sept. 29, 2026 /PRNewswire/ -- As the world observes the 2026 United Nations International Day of Older Persons under the theme "The Age of Longevity: Rethinking Systems for Longer Lives ," global attention is turning toward ...

2026-09-30 01:50 2641

Oracle Unveils Fusion Claw + Expands Agentic Applications: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 29, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...

2026-09-29 21:03 5664

RevitaLash® Cosmetics Introduces RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, a Revolutionary Lash Serum Made without Prostaglandin Analogues

Ophthalmologist-developed and clinically tested, the new peptide-powered formula pairs advanced time-release technology with high-performance lash conditioning VENTURA, Calif., Sept. 29, 2026 /PRNewswire/ -- RevitaLash® Cosmetics, the internationally recognized leader in lash, brow, and hair car...

2026-09-29 21:01 5703

Yuyu Teijin Medicare Uses Drones to Deliver Medical Supplies to Patients on Korea's Remote Islands

SEOUL, South Korea, Sept. 29, 2026 /PRNewswire/ -- Yuyu Teijin Medicare, a home healthcare joint venture between Yuyu Pharma of Korea and Teijin Pharma of Japan, has completed a pilot delivery of medical supplies by drone to a ventilator patient living on a remote Korean island. In the test, a d...

2026-09-29 21:00 2442

Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses

Developed to fit around nursing workflows, ClinicalKey Nursing AI gives nurses fast, traceable answers to clinical questions at the point of care. NEW YORK, Sept. 29, 2026 /PRNewswire/ -- Today Elsevier announced the global launch of ClinicalKey Nursing AI, the clinical AI tool built specifically...

2026-09-29 20:00 2877

Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses

Developed to fit around nursing workflows, ClinicalKey Nursing AI gives nurses fast, traceable answers to clinical questions at the point of care NEW YORK, Sept. 29, 2026 /PRNewswire/ -- Today Elsevier announced the global launch of ClinicalKey Nursing AI, the clinical AI tool built specifically ...

2026-09-29 20:00 1882

CAS announces collaboration with Novartis to advance AI-ready reaction informatics

Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis  COLUMBUS, Ohio, Sept. 29, 2026 /PRNewswire/ -- CAS, a division of the American Chemical Society, today announced a collaboration with Novartis Bio...

2026-09-29 20:00 1868

Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board

CALGARY, AB, Sept. 29, 2026 /PRNewswire/ -- Providence Therapeutics Holdings, Inc. is pleased to announce formation of its initial Clinical Advisory Board. This advisory group will help steer Providence's therapeutic mRNA cancer vaccine programs, including the Company's personalized vaccine progr...

2026-09-29 19:00 1454

iRegene Therapeutics's NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

- Following its Parkinson's disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. CHENGDU, China, Sept. 29, 2026 /PRNewswire/ -- iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemical...

2026-09-29 13:41 2328

Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596

* HRS-1596 is a phase I-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing           * Total potential deal value is up to 2.6 billion US dollars, including 300 million dollars upfront, as well as potential sales royalties SHANGHAI, Sept. 29, 2026 /PRNewswire/ -- Hengrui Pharm...

2026-09-29 13:12 2572

Vitaceuticals Founders Win National Manufacturing Award for Australian-Made Health Range

Pharmacists Sally Tadros and Cyndi Khawaja recognised at the 2026 Australian Women's Small Business Champion Awards. SYDNEY, Sept. 29, 2026 /PRNewswire/ -- Sydney pharmacists and sisters Sally Tadros and Cyndi Khawaja have won the Manufacturing category at the 2026 Australian Women's Small Busin...

2026-09-29 09:16 1343

Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor for the Treatment of Plaque Psoriasis

- 48.9% placebo-adjusted reduction in psoriasis area and severity index (PASI) score achieved in mild-to-moderate plaque psoriasis patients with once-daily 200 mg 28-day treatment. - Steady-state elimination half-life after 28-day treatment in patients was 6.5 days, supporting potential once-wee...

2026-09-29 08:00 2865

Regent Pacific (0575.HK)'s Deep Longevity Launches Accrua™ US Consumer Digital Health and Telehealth Platform

Available Across All 50 US States, Extending Deep Longevity's AI-Powered Ageing Science Directly to Consumers for a Second Growth Curve HONG KONG, Sept. 28, 2026 /PRNewswire/ -- Regent Pacific Group Limited (" Regent Pacific" or the "Company", together with its subsidiaries, the "Group"; stock co...

2026-09-28 23:29 4157

Open-Source Model Accelerates Global Progress in Medical Video AI

SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- Through an open-source model, a public dataset and benchmark, and the MedVidU Challenge, a global research competition, researchers worldwide now share a common foundation for advancing medical video AI. The Challenge drew 75 teams from 18 countries and re...

2026-09-28 21:19 3781

Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region

Following years of clinical validation and proven real-world performance at Saint Göran, Stockholm Region adopts Lunit INSIGHT MMG as an independent second reader at regional scale SEOUL, South Korea, Sept. 28, 2026 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnost...

2026-09-28 21:00 2794

Heidi II puts agents to work on visit admin, giving clinicians more time with patients

Heidi II brings agentic capability into existing clinical workflows, moving from documenting the visit to doing the routine work around it with clinician supervision. MELBOURNE, Australia, Sept. 28, 2026 /PRNewswire/ -- Heidi , the AI Care Partner for leading clinic...

2026-09-28 21:00 2500

Link Cell Therapies Initiates Clinical Dosing with Logic-Gated CAR-T Therapy, Expands Executive Leadership, and Upsizes Series A Financing to $90 Million

– LNK001, an AND-gated CAR-T therapy targeting CAIX and ENPP3, is being evaluated in a Phase 1 study in advanced clear cell renal cell carcinoma at MD Anderson Cancer Center – – Jie D'Elia, Ph.D., joins as Chief Executive Officer and Friedrich Graf Finckenstein, M.D., as Chief Medical Officer; c...

2026-09-28 18:59 2947

Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy

SAN FRANCISCO and SUZHOU, China, Sept. 28, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabol...

2026-09-28 18:30 2817

CityUHK researchers advance spatial omics to routine clinical use

HONG KONG, Sept. 28, 2026 /PRNewswire/ -- Recently, spatial omics has become a powerful tool, enabling researchers to see not only what molecules are present in a tissue, but also where they are located and how they are organised across cells, tissue structures and local microenvironments. This s...

2026-09-28 17:55 1986

111, Inc. Announces Establishment of the Special Committee

SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directors, Mr. Jian Sun, who is the chairma...

2026-09-28 16:30 4146
1 ... 16171819202122 ... 642